medigraphic.com

2018, Number 4

<< Back Next >>

Rev Fac Med UNAM 2018; 61 (4)

Thyroiditis as a consequence of the application of iodine 131

Rubalcava LLF, Juárez RJI

Language: Spanish
References: 12
Page: 30-34
PDF size: 148.13 Kb.


ABSTRACT

Thyroiditis is an inflammatory disease of the thyroid gland. The most common etiologies are autoimmune and infectious but the exposure to therapeutic radioactive agents such as I131 has not been reported as a cause. The use of I131 is usually a safe procedure with no common adverse effects, nevertheless ‹1% of the patients might present inflammation of the thyroid gland and nearby soft tissue known as I131 secondary radiation thyroiditis. The diagnosis is clinical after discarding other common etiologies. The optimal treatment is controversial and includes different experts and guides indicating different drugs and doses. The prognosis is good and with no long-term consequences


REFERENCES

  1. Sarkany RP. Ultraviolet radiation and the skin. En: Nriagu JO (Ed). Encyclopedia of Environmental Heath, New York: Elsevier, 2011. p. 469.

  2. Donya M, Radford M, ElGuindy A, et al. Radiation in medicine: Origin, risks and aspirations. Glob Cardiol Sci Pract. 2014;2014(4):437-48.

  3. Barnett GC, West CM, Dunning AM, et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer. 2009;9(2):134.

  4. Amundson SA, Bittner M, Meltzer P, et al. Physiological function as regulation of large transcriptional programs: the cellular response to genotoxic stress. Comp Biochem Physiol B Biochem Mol Biol. 2001;129(4):703.

  5. Mizokami T, Hamada K, Maruta T, et al. Painful radiation thyroiditis: after 131I therapy for Graves hyperthyriodism: clinical features and ultrasonographic findings in five cases. Eur Thyroid J. 2016;5:201-6.

  6. Shah KK, Tarasova V, Davidian M, et al. Painful acute radiation thyroiditis indiced by 131I treatment of Graves disease. BMJ Case Rep. 2015.doi:10.1136/bcr-2014-207670.

  7. Bahn R, Burch H, Cooper D , et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endrocrinologists. Thyroid. 2011;21:593- 646.

  8. Cherk MH, Kalff V, Yap KS, et al. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma. Clin Endocrinol. 2008;69:957-62.

  9. Bonnema SJ, Hegedus L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev.2012;33(6):920-80.

  10. Yamashiro I, Cassio-Saito O, Chammas MC, et al. Ultrasound findings in thyroiditis. Radiol Bras. 2007;40(2):75-9.

  11. Ross DS, Burch HB, Cooper S, et al. 2016 American Thyroid Association for Diagnosis and management of Hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016; 26(10):1343-421.

  12. Véliz L Jesús, Pineda V Gustavo, Arancibia Z Paulina, Wohllk G Nelson. Tratamiento con radioyodo del bocio difuso hipertiroideo: influencia del pretratamiento con propiltiuracilo. Rev méd Chile [Internet]. 2000 Jun [citado 2017 Jun 01];128(6):609- 12. Disponible en: http://www.scielo.cl/scielo.php?script=sci_ arttext&pid=S0034-98872000000600006&lng=es. http:// dx.doi.org/10.4067/S0034-98872000000600006.




2020     |     www.medigraphic.com